Advisory Services Network, LLC Celldex Therapeutics, Inc. Transaction History

Advisory Services Network, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $5,556 - $9,076	200 New	200 $8,000
Q3 2021 Nov 05, 2021	SELL	$28.95 - $55.99 $492 - $951	-17 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$20.71 - $35.37 $352 - $601	17 New	17 $1,000
Q1 2021 May 24, 2021	SELL	$16.19 - $29.91 $275 - $508	-17 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$9.65 - $15.19 $164 - $258	17 New	17 $0
Q2 2020 Aug 10, 2020	SELL	$1.61 - $13.41 $27 - $227	-17 Closed	0 $0
Q1 2019 May 20, 2019	BUY	$3.45 - $10.35 $58 - $175	17 New	17 $0

199

65.9M

1.68M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.15B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.